| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AMARIN CORP PLC | 200,000 | 218,000 | 0.12% | ||
| 2 | FLEXION THERAPEUTICS INC COM | 12,488 | 228,000 | 0.12% | ||
| 3 | Wright Medical Group Inc | 134,000 | 288,000 | 0.16% | ||
| 4 | CATALYST PHARMACEUTICALS INC | 100,000 | 332,000 | 0.18% | Put | |
| 5 | UNILIFE CORP | 150,000 | 344,000 | 0.19% | ||
| 6 | PSIVIDA CORP | 100,000 | 442,000 | 0.24% | ||
| 7 | ASSEMBLY BIOSCIENCES INC | 65,000 | 532,000 | 0.29% | ||
| 8 | LIPOCINE INC NEW | 91,768 | 561,000 | 0.30% | ||
| 9 | HERON THERAPEUTICS INC | 70,000 | 583,000 | 0.32% | ||
| 10 | OCERA THERAPEUTICS INC | 125,000 | 613,000 | 0.33% | ||
| 11 | BIOLASE INC | 300,000 | 747,000 | 0.41% | ||
| 12 | Receptos Inc | 12,300 | 764,000 | 0.41% | ||
| 13 | ALCOBRA LTD | 50,000 | 772,000 | 0.42% | Call | |
| 14 | NANOSTRING TECHNOLOGIES INC | 90,000 | 985,000 | 0.53% | ||
| 15 | VANDA PHARMACEUTICALS INC | 100,000 | 1,038,000 | 0.56% | Call | |
| 16 | ALIMERA SCIENCES INC | 200,000 | 1,084,000 | 0.59% | Put | |
| 17 | PUMA BIOTECHNOLOGY | 5,000 | 1,193,000 | 0.65% | ||
| 18 | AGIOS PHARMACEUTICALS INC | 20,000 | 1,227,000 | 0.67% | ||
| 19 | BLUEBIRD BIO INCORPORATED | 35,000 | 1,256,000 | 0.68% | ||
| 20 | SMITH & NEPHEW PLC SPDN ADR NEW | 15,000 | 1,263,000 | 0.69% | ||
| 21 | ONCOTHYREON INC COM N/C EFF 6/ | 700,000 | 1,344,000 | 0.73% | ||
| 22 | ENANTA PHARMACEUTICALS INC COM | 35,000 | 1,385,000 | 0.75% | ||
| 23 | ZAFGEN INC COM | 75,000 | 1,474,000 | 0.80% | ||
| 24 | ACHILLION PHARMACEUTICALS INC | 150,000 | 1,497,000 | 0.81% | Call | |
| 25 | NEUROCRINE BIOSCIE COM USD0.001 | 100,000 | 1,567,000 | 0.85% | ||
| 26 | AVALANCHE BIOTECHNOLOGIES IN | 50,000 | 1,710,000 | 0.93% | ||
| 27 | NUVASIVE INC COM | 50,000 | 1,744,000 | 0.95% | ||
| 28 | TANDEM DIABETES CARE INC | 131,500 | 1,765,000 | 0.96% | ||
| 29 | DEPOMED INC | 120,000 | 1,823,000 | 0.99% | ||
| 30 | MEDTRONIC INC | 30,000 | 1,859,000 | 1.01% | ||
| 31 | AEGERION PHARMACEUTICALS INC | 60,000 | 2,003,000 | 1.09% | ||
| 32 | ANTARES PHARMA INC | 1,100,000 | 2,013,000 | 1.09% | ||
| 33 | PTC THERAPEUTICS INC | 50,000 | 2,201,000 | 1.19% | ||
| 34 | CHIMERIX INC | 80,500 | 2,223,000 | 1.21% | ||
| 35 | EXACT SCIENCES CORP | 125,000 | 2,423,000 | 1.32% | ||
| 36 | EDWARDS LIFESCIENCES CORP | 25,000 | 2,554,000 | 1.39% | ||
| 37 | BRUKER CORP | 140,000 | 2,592,000 | 1.41% | ||
| 38 | SPECTRANETICS CORP | 100,000 | 2,657,000 | 1.44% | ||
| 39 | QUIDEL CORP COM | 100,000 | 2,687,000 | 1.46% | ||
| 40 | ALNYLAM PHARMACEUTICALS INC | 35,000 | 2,734,000 | 1.48% | ||
| 41 | GW PHARMACEUTICALS PLC | 35,000 | 2,830,000 | 1.54% | ||
| 42 | PORTOLA PHARMACEUTICALS INC | 115,000 | 2,907,000 | 1.58% | ||
| 43 | CLOVIS ONCOLOGY INC | 65,000 | 2,948,000 | 1.60% | ||
| 44 | NEUROCRINE BIOSCIENCES INC | 200,000 | 3,134,000 | 1.70% | Call | |
| 45 | VALEANT PHARMACEUTICALS INTL | 25,000 | 3,280,000 | 1.78% | ||
| 46 | ZS PHARMA INC | 85,000 | 3,335,000 | 1.81% | ||
| 47 | ENVISION HEALTHCARE HLDGS INC | 100,000 | 3,468,000 | 1.88% | ||
| 48 | THERAPEUTICSMD INC | 750,000 | 3,480,000 | 1.89% | ||
| 49 | CONCERT PHARMACEUTICALS INC COM | 280,966 | 3,543,000 | 1.92% | ||
| 50 | ALLERGAN PLC | 15,000 | 3,619,000 | 1.96% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001164691-14-000217, filed 2014.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
